These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37523056)

  • 1. Eight Strategies to Engineer Acceptance of Human Germline Modifications.
    Khan S; Drabiak K
    J Bioeth Inq; 2024 Mar; 21(1):81-94. PubMed ID: 37523056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline Modification and Policymaking: The Relationship between Mitochondrial Replacement and Gene Editing.
    Cussins J; Lowthorp L
    New Bioeth; 2018 Apr; 24(1):74-94. PubMed ID: 29529982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Germ Line and Heritable Genome Editing: The Global Policy Landscape.
    Baylis F; Darnovsky M; Hasson K; Krahn TM
    CRISPR J; 2020 Oct; 3(5):365-377. PubMed ID: 33095042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Democratic Governance of Human Germline Genome Editing.
    Jasanoff S; Hurlbut JB; Saha K
    CRISPR J; 2019 Oct; 2(5):266-271. PubMed ID: 31599682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of scientific self-regulation for the control of genome editing in the human germline: The lessons from the Asilomar and the Napa meetings show how self-regulation and public deliberation can lead to regulation of new biotechnologies.
    Gregorowius D; Biller-Andorno N; Deplazes-Zemp A
    EMBO Rep; 2017 Mar; 18(3):355-358. PubMed ID: 28219901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsible governance of human germline genome editing in China†.
    Peng Y; Lv J; Ding L; Gong X; Zhou Q
    Biol Reprod; 2022 Jul; 107(1):261-268. PubMed ID: 35640230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Playing it Safe? Precaution, Risk, and Responsibility in Human Genome Editing.
    Chan S
    Perspect Biol Med; 2020; 63(1):111-125. PubMed ID: 32063591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heritable Genome Editing and the Downsides of a Global Moratorium.
    Macintosh KL
    CRISPR J; 2019 Oct; 2(5):272-279. PubMed ID: 31599680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Mitochondrial Replacement" Technologies and Human Germline Nuclear Modification.
    Lane A; Nisker J
    J Obstet Gynaecol Can; 2016 Aug; 38(8):731-6. PubMed ID: 27638985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulating germline editing in assisted reproductive technology: An EU cross-disciplinary perspective.
    Nordberg A; Minssen T; Feeney O; de Miguel Beriain I; Galvagni L; Wartiovaara K
    Bioethics; 2020 Jan; 34(1):16-32. PubMed ID: 31877579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Human Right to Science and the Regulation of Human Germline Engineering.
    Boggio A; Knoppers BM; Almqvist J; Romano CPR
    CRISPR J; 2019 Jun; 2():134-142. PubMed ID: 31225756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heritable Human Genome Editing: The Public Engagement Imperative.
    Adashi EY; Burgess MM; Burall S; Cohen IG; Fleck LM; Harris J; Holm S; Lafont C; Moreno JD; Neblo MA; Niemeyer SJ; Rowe EJ; Scheufele DA; Tetsa PF; Vayena E; Watermeyer RP; Fung A
    CRISPR J; 2020 Dec; 3(6):434-439. PubMed ID: 33346718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Editing: A View Through the Prism of Inherited Metabolic Disorders.
    Davison J
    New Bioeth; 2018 Apr; 24(1):2-8. PubMed ID: 29529978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline genome editing: Moratorium, hard law, or an informed adaptive consensus?
    Kaan T; Xafis V; Schaefer GO; Zhu Y; Labude MK; Chadwick R
    PLoS Genet; 2021 Sep; 17(9):e1009742. PubMed ID: 34499642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making sense of heritable human genome editing: Scientific and ethical considerations.
    Greenfield A
    Prog Mol Biol Transl Sci; 2021; 182():1-28. PubMed ID: 34175039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating Demand for Germline Genome Editing: An
    Viotti M; Victor AR; Griffin DK; Groob JS; Brake AJ; Zouves CG; Barnes FL
    CRISPR J; 2019 Oct; 2(5):304-315. PubMed ID: 31599685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does human genome editing reinforce or violate human dignity?
    Segers S; Mertes H
    Bioethics; 2020 Jan; 34(1):33-40. PubMed ID: 31222790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why Include the Public in Genome Editing Governance Deliberation?
    Blasimme A
    AMA J Ethics; 2019 Dec; 21(12):E1065-1070. PubMed ID: 31876471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline genome-editing research and its socioethical implications.
    Ishii T
    Trends Mol Med; 2015 Aug; 21(8):473-81. PubMed ID: 26078206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The illusion of control in germline-engineering policy.
    König H
    Nat Biotechnol; 2017 Jun; 35(6):502-506. PubMed ID: 28591117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.